His communication style has been like this since he started speaking on AMRN's investor calls in 2012 or so. If he hasn't improved over the last six years, then he won't for the next ten years. The next nine years are the best time for them to monetize the drug. They need every opportunity to educate and communicate with the public about Vascepa! They are squandering these away right now.
JT is a very competent executive but he really needs to delegate public communication to someone else such as CMO Craig Granowitz who is a much better speaker and completely qualified for this responsibility. The company also needs a better PR firm/team to write more impactful scripts for him and others.
It's just another important issue they need to address if they are serious about GIA. Doesn't seem they care about this so far.
News 
Market Data 
Discover 
AI
